Furthermore, significantly reduced invasive ability was also witnessed in SaoS-2 osteosarcoma cells upon PSMC2 knockdown determined by a transwell based invasion assay (Figure 8b & 8d). The gene discussed is PSMC2; the disease is osteosarcoma.